About Technology Issues FAQ

Links

Hemoglobin Levels Triggering Erythropoiesis‐Stimulating Agent Therapy in Patients with Cancer: the Shift After United States Food and Drug Administration Policy Changes

Hemoglobin Levels Triggering Erythropoiesis‐Stimulating Agent Therapy in Patients with Cancer: the Shift After United States Food and Drug Administration Policy Changes — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.